Trastuzumab Recruiting Phase 2 Trials for Stage IV Breast Cancer / Stage III Breast Cancer / HER2 Positive Breast Carcinoma / Stage IIIC Breast Cancer / Stage IIIB Breast Cancer / Stage IIIA Breast Cancer Treatment

IndicationsStatusPurposePhase
RecruitingTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT03179904FASN Inhibitor TVB-2640, Paclitaxel, and Trastuzumab in Treating Patients With HER2 Positive Advanced Breast Cancer